Home > Press > Innovative Nanotechnology Research Nets International Recognition for George Mason University Scientist
Alessandra Luchini, a scientist in George Mason University's Center for Applied Proteomics and Molecular Medicine, has captured the inaugural Premio Award for the top Italian woman scientist in North America. She recently was honored in a ceremony in Milan, Italy, by award presenters Bridges to Italy, an international business association, and the Italian Women Inventors and Innovators Network (ITWIIN).
Innovative Nanotechnology Research Nets International Recognition for George Mason University Scientist
MANASSAS, VA | Posted on June 22nd, 2009
The competition attracted more than 40 Italian women scientists working in the fields of life sciences, nanotechnology, or alternative energy and the environment. A jury of experts selected three finalists on the basis of the worthiness of their research to society, business and the scientific community, and the final selection was made online by interested voters.
"I decided to compete for the Premio Award because I recognize the importance of bringing public attention to research accomplishments in order to get continuous support for our work to improve the health of patients worldwide," says Luchini. "I also think it is very important that women's roles in research are recognized and celebrated."
Luchini was selected for her contributions to the development of smart hydrogel nanoparticles that mix with a patient's blood or urine sample to instantly soak up protein biomarkers and protect them from degradation when they are extracted for analysis. The invention is recognized as a breakthrough in biomarker discovery and analysis because it immediately preserves, protects and stabilizes the molecules -- something no other technology has been shown to do.
"My invention is a technology that relates to the war against cancer," Luchini explains. "We all have relatives or friends suffering from the disease. It is recognized that early diagnosis can save lives, so it is important to detect cancer when it is a small lesion and prior to metastasis." The nanoparticles are being used to identify biomarkers for cancer and other diseases, and their potential use in a urine-based anti-doping test to detect human growth hormone also is under study, she adds.
Ceres Nanosciences LLLP, a Virginia-based biotechnology company, has commercialized the invention as the Nanotrapô. A number of applications for high-demand diagnostics and other needs in the life sciences industry are currently under development.
Luchini originally came to Mason from Italy to participate in an unprecedented proteomics research program between the university and the Instituto Superiore di Sanita` in Rome. The program, designed to unveil new cancer diagnostics and therapies through the discovery of drug targets and biomarkers for early disease detection, is in its fourth year.
Bridges to Italy and ITWIIN provide opportunities to Italian scientists around the world for recognition in the scientific and business communities, international networking, and business and research collaboration.
About George Mason University
Named the #1 national university to watch by U.S. News & World Report, George Mason University is an innovative, entrepreneurial institution with global distinction in a range of academic fields. Located in the heart of Northern Virginiaís technology corridor near Washington, D.C., Mason prepares its students to succeed in the work force and meet the needs of the region and the world. With strong undergraduate and graduate degree programs in engineering and information technology, dance, organizational psychology and health care, Mason students are routinely recognized with national and international scholarships. Mason professors conduct groundbreaking research in areas such as cancer, climate change, information technology and the biosciences, and Masonís Center for the Arts brings world-renowned artists, musicians and actors to its stage.
For more information, please click here
Copyright © George Mason University
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
News and information
NREL Announces New Center Directors to lead R&D, Analysis Efforts September 30th, 2014
Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence: Yale Welcomes Scientists to Participate in Core Facility Opening and Super- Resolution Workshops October 20 Through 31, 2014 September 30th, 2014
Speed at its limits September 30th, 2014
Research mimics brain cells to boost memory power September 30th, 2014
Park Systems Announces Outsourced Analytical Services Including AFM Surface Imaging, Data Analysis and Interpretation September 30th, 2014
Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014
New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014
Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014
A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014
Teijin Aramidís carbon nanotube fibers awarded with Paul Schlack prize: New generation super fibers bring wave of innovations to fiber market September 25th, 2014
New chip promising for tumor-targeting research September 22nd, 2014
SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014